Liquid Biopsy Cell-Free PAN RAS (KRAS, NRAS) Test
Revolutionary Non-Invasive Cancer Genetic Testing
The Liquid Biopsy Cell-Free PAN RAS (KRAS, NRAS) Test represents a groundbreaking advancement in cancer diagnostics and personalized medicine. This innovative test analyzes circulating tumor DNA (ctDNA) from a simple blood sample to detect specific mutations in the RAS gene family, which includes KRAS and NRAS genes. These genetic alterations play a pivotal role in cancer development, progression, and treatment response across multiple cancer types.
What This Advanced Test Measures
Our comprehensive PAN RAS liquid biopsy test specifically detects:
- KRAS mutations – Critical driver mutations in codons 12, 13, and 61
- NRAS mutations – Important genetic alterations affecting treatment selection
- RAS family genetic variants – Comprehensive analysis of the entire RAS pathway
Who Should Consider This Genetic Test?
This advanced liquid biopsy test is particularly beneficial for individuals experiencing:
- Patients with diagnosed colorectal cancer seeking targeted therapy options
- Individuals with lung cancer requiring EGFR inhibitor treatment planning
- Pancreatic cancer patients for comprehensive genetic profiling
- Those with metastatic disease requiring treatment monitoring
- Patients showing resistance to current cancer therapies
- Individuals needing minimal residual disease detection
Clinical Indications and Symptoms
The test is recommended for patients presenting with symptoms or conditions including unexplained weight loss, persistent fatigue, abnormal bleeding, chronic pain, or those with established cancer diagnoses requiring genetic characterization for treatment optimization.
Significant Benefits of PAN RAS Testing
- Non-Invasive Procedure – Simple blood draw eliminates need for tissue biopsies
- Comprehensive Genetic Analysis – Simultaneous detection of KRAS and NRAS mutations
- Personalized Treatment Planning – Guides selection of targeted therapies
- Treatment Monitoring – Tracks response to therapy and detects resistance
- Early Detection Capability – Identifies genetic changes before clinical symptoms appear
- Minimal Residual Disease Assessment – Monitors cancer recurrence risk
Understanding Your Test Results
Your PAN RAS liquid biopsy results will provide clear genetic information:
- Positive for Mutation – Indicates presence of specific RAS mutations that may guide targeted therapy selection
- Negative for Mutation – Suggests absence of detectable RAS mutations, potentially opening alternative treatment options
- Variant of Unknown Significance – Rare genetic changes requiring further clinical correlation
All results include detailed interpretation by our expert genetic counselors and oncologists to ensure proper understanding and clinical application.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Liquid Biopsy Cell-Free PAN RAS (KRAS, NRAS) Test | $676 USD | $900 USD |
Test Specifications
- Turnaround Time: 5-7 days
- Sample Type: Peripheral Blood (Streck Tube)
- Testing Method: Droplet Digital PCR
- Specialty: Oncology Genetics
Convenient Nationwide Access
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Book Your Test Today
Take the first step toward personalized cancer care with our advanced PAN RAS liquid biopsy testing. Our expert team is ready to assist you with scheduling and answer any questions about this revolutionary genetic testing approach.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or learn more about how this test can benefit your cancer care journey.
Important Pre-Test Information
The Liquid Biopsy Cell-Free PAN RAS (KRAS, NRAS) Test requires a physician’s prescription for most cases. Prescription requirements do not apply for surgical planning, pregnancy-related testing, or international travel purposes. Please consult with your healthcare provider to determine if this test is appropriate for your specific medical situation.
